{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:16:42Z","timestamp":1794352602897,"version":"4.9.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02382-0","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:11:30Z","timestamp":1740640290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiple roles of circular RNAs in prostate cancer: from the biological basis to potential clinical applications"],"prefix":"10.1186","volume":"30","author":[{"given":"Xianping","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoutian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"2382_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review. Eur Urol. 2023;84:191\u2013206.","journal-title":"Eur Urol"},{"key":"2382_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eururo.2018.03.028","volume":"75","author":"P Nuhn","year":"2019","unstructured":"Nuhn P, De Bono JS, Fizazi K, Freedland SJ, Grilli M, Kantoff PW, et al. Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology. Eur Urol. 2019;75:88\u201399.","journal-title":"Eur Urol"},{"key":"2382_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12967-018-1582-8","volume":"16","author":"J Cheng","year":"2018","unstructured":"Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng J, et al. Regulatory network of circRNA\u2013miRNA\u2013mRNA contributes to the histological classification and disease progression in gastric cancer. J Transl Med. 2018;16:216.","journal-title":"J Transl Med"},{"key":"2382_CR4","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA. 1976;73:3852\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2382_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40001-023-01001-0","volume":"28","author":"X Li","year":"2023","unstructured":"Li X, Guo L, Wang J, Yang X. Pro-fibrotic and apoptotic activities of circARAP1 in myocardial ischemia\u2013reperfusion injury. Eur J Med Res. 2023;28:84.","journal-title":"Eur J Med Res"},{"key":"2382_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s40001-023-01288-z","volume":"28","author":"Q Xie","year":"2023","unstructured":"Xie Q, Qin F, Luo L, Deng S, Zeng K, Wu Y, et al. hsa_circ_0003596, as a novel oncogene, regulates the malignant behavior of renal cell carcinoma by modulating glycolysis. Eur J Med Res. 2023;28:315.","journal-title":"Eur J Med Res"},{"key":"2382_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110006","volume":"117","author":"X Liu","year":"2023","unstructured":"Liu X, Dou B, Tang W, Yang H, Chen K, Wang Y, et al. Cardioprotective effects of circ_0002612 in myocardial ischemia\/reperfusion injury correlate with disruption of miR-30a-5p-dependent Ppargc1a inhibition. Int Immunopharmacol. 2023;117: 110006.","journal-title":"Int Immunopharmacol"},{"key":"2382_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s40001-024-01753-3","volume":"29","author":"S Huang","year":"2024","unstructured":"Huang S, Wu Z, Zhou Y. Hypoxia-induced circRNAs encoded by PPARA are highly expressed in human cardiomyocytes and are potential clinical biomarkers of acute myocardial infarction. Eur J Med Res. 2024;29:159.","journal-title":"Eur J Med Res"},{"key":"2382_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40001-022-00679-y","volume":"27","author":"Q Liu","year":"2022","unstructured":"Liu Q, Cui Y, Ding N, Zhou C. Knockdown of circ_0003928 ameliorates high glucose-induced dysfunction of human tubular epithelial cells through the miR-506-3p\/HDAC4 pathway in diabetic nephropathy. Eur J Med Res. 2022;27:55.","journal-title":"Eur J Med Res"},{"key":"2382_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.omtn.2021.10.017","volume":"26","author":"X Liu","year":"2021","unstructured":"Liu X, Tong Y, Xia D, Peng E, Yang X, Liu H, et al. Circular RNAs in prostate cancer: biogenesis, biological functions, and clinical significance. Mol Ther Nucleic Acids. 2021;26:1130\u201347.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2382_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453\u201361.","journal-title":"Nat Biotechnol"},{"key":"2382_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141\u201357.","journal-title":"RNA"},{"key":"2382_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.celrep.2014.12.019","volume":"10","author":"A Ivanov","year":"2015","unstructured":"Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015;10:170\u20137.","journal-title":"Cell Rep"},{"key":"2382_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10555-023-10152-9","volume":"43","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Gao Z, Fang H, Zhao Y, Xing R. Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance. Cancer Metastasis Rev. 2024;43:867\u201388.","journal-title":"Cancer Metastasis Rev"},{"key":"2382_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111510","volume":"125","author":"X Shu","year":"2025","unstructured":"Shu X, Yi J, Li J, Ying Y, Tang Y, Chen Z, et al. N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1\/PCNA axis. Cell Signal. 2025;125: 111510.","journal-title":"Cell Signal"},{"key":"2382_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-023-01766-2","volume":"22","author":"ZH Zhang","year":"2023","unstructured":"Zhang ZH, Wang Y, Zhang Y, Zheng SF, Feng T, Tian X, et al. The function and mechanisms of action of circular RNAs in urologic cancer. Mol Cancer. 2023;22:61.","journal-title":"Mol Cancer"},{"key":"2382_CR17","first-page":"1045","volume":"13","author":"S Ge","year":"2020","unstructured":"Ge S, Sun C, Hu Q, Guo Y, Xia G, Mi Y, et al. Differential expression profiles of circRNAs in human prostate cancer based on chip and bioinformatic analysis. Int J Clin Exp Pathol. 2020;13:1045\u201352.","journal-title":"Int J Clin Exp Pathol"},{"key":"2382_CR18","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1159\/000494870","volume":"50","author":"Q Xia","year":"2018","unstructured":"Xia Q, Ding T, Zhang G, Li Z, Zeng L, Zhu Y, et al. Circular RNA expression profiling identifies prostate cancer-specific circRNAs in prostate cancer. Cell Physiol Biochem. 2018;50:1903\u201315.","journal-title":"Cell Physiol Biochem"},{"key":"2382_CR19","doi-asserted-by":"crossref","unstructured":"Zhang C, Xiong J, Yang Q, Wang Y, Shi H, Tian Q, et al. Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells. Future Sci OA. 2018;4:FSOA340.","DOI":"10.4155\/fsoa-2018-0046"},{"key":"2382_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152784","volume":"216","author":"Z Yan","year":"2020","unstructured":"Yan Z, Xiao Y, Chen Y, Luo G. Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer. Pathol Res Pract. 2020;216: 152784.","journal-title":"Pathol Res Pract"},{"key":"2382_CR21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fgene.2020.00892","volume":"11","author":"YP Wu","year":"2020","unstructured":"Wu YP, Lin XD, Chen SH, Ke ZB, Lin F, Chen DN, et al. Identification of prostate cancer-related circular RNA through bioinformatics analysis. Front Genet. 2020;11:892.","journal-title":"Front Genet"},{"key":"2382_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-022-01630-9","volume":"21","author":"T Xie","year":"2022","unstructured":"Xie T, Fu DJ, Li ZM, Lv DJ, Song XL, Yu YZ, et al. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322\/CCL20\/CCR6 signaling. Mol Cancer. 2022;21:173.","journal-title":"Mol Cancer"},{"key":"2382_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.7555\/JBR.38.20240030","volume":"38","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Shi R, Ben S, Chen S, Li S, Xin J, et al. Genetic variation of circHIBADH enhances prostate cancer risk through regulating HNRNPA1-related RNA splicing. J Biomed Res. 2024;38:358\u201368.","journal-title":"J Biomed Res"},{"key":"2382_CR24","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","volume":"42","author":"G Pisignano","year":"2023","unstructured":"Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023;42:2783\u2013800.","journal-title":"Oncogene"},{"key":"2382_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ccell.2017.02.004","volume":"31","author":"M Blattner","year":"2017","unstructured":"Blattner M, Liu D, Robinson BD, Huang D, Poliakov A, Gao D, et al. SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K\/mTOR and AR signaling. Cancer Cell. 2017;31:436\u201351.","journal-title":"Cancer Cell"},{"key":"2382_CR26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/cncr.31921","volume":"125","author":"SZ Millis","year":"2019","unstructured":"Millis SZ, Jardim DL, Albacker L, Ross JS, Miller VA, Ali SM, et al. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities. Cancer. 2019;125:1185\u201399.","journal-title":"Cancer"},{"key":"2382_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376.","journal-title":"Cell"},{"key":"2382_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112233","volume":"395","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhang X, Chen G, Zheng X, Zhu X, Shan L. Hsa_circ_0007494 suppresses prostate cancer progression via miR-616\/PTEN axis. Exp Cell Res. 2020;395: 112233.","journal-title":"Exp Cell Res"},{"key":"2382_CR29","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2147\/CMAR.S190669","volume":"11","author":"D Chen","year":"2019","unstructured":"Chen D, Lu X, Yang F, Xing N. Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression. Cancer Manag Res. 2019;11:1415\u201323.","journal-title":"Cancer Manag Res"},{"key":"2382_CR30","doi-asserted-by":"publisher","first-page":"11883","DOI":"10.2147\/CMAR.S267927","volume":"12","author":"B Huang","year":"2020","unstructured":"Huang B, Zhou D, Huang X, Xu X, Xu Z. Silencing circSLC19A1 inhibits prostate cancer cell proliferation, migration and invasion through regulating miR-326\/MAPK1 axis. Cancer Manag Res. 2020;12:11883\u201395.","journal-title":"Cancer Manag Res"},{"key":"2382_CR31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.ijbiomac.2018.09.076","volume":"122","author":"J Si-Tu","year":"2019","unstructured":"Si-Tu J, Cai Y, Feng T, Yang D, Yuan S, Yang X, et al. Upregulated circular RNA circ-102004 that promotes cell proliferation in prostate cancer. Int J Biol Macromol. 2019;122:1235\u201343.","journal-title":"Int J Biol Macromol"},{"key":"2382_CR32","doi-asserted-by":"publisher","first-page":"2178802","DOI":"10.1080\/15592294.2023.2178802","volume":"18","author":"X Dai","year":"2023","unstructured":"Dai X, Chen X, Chen W, Ou Y, Chen Y, Wu S, et al. CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3\/miR-421\/MEIS2 axis. Epigenetics. 2023;18:2178802.","journal-title":"Epigenetics"},{"key":"2382_CR33","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.7150\/jca.86940","volume":"14","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Qin J, Song C, Wu T, Quan Q, Zhang Y, et al. circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. J Cancer. 2023;14:2574\u201384.","journal-title":"J Cancer"},{"key":"2382_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.4149\/neo_2019_190213N116","volume":"67","author":"H Jiang","year":"2020","unstructured":"Jiang H, Lv DJ, Song XL, Wang C, Yu YZ, Zhao SC. Upregulated circZMIZ1 promotes the proliferation of prostate cancer cells and is a valuable marker in plasma. Neoplasma. 2020;67:68\u201377.","journal-title":"Neoplasma"},{"key":"2382_CR35","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.2147\/OTT.S242482","volume":"13","author":"F Liu","year":"2020","unstructured":"Liu F, Fan Y, Ou L, Li T, Fan J, Duan L, et al. CircHIPK3 facilitates the G2\/M transition in prostate cancer cells by sponging miR-338-3p. Onco Targets Ther. 2020;13:4545\u201358.","journal-title":"Onco Targets Ther"},{"key":"2382_CR36","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.2147\/OTT.S196931","volume":"12","author":"C Cai","year":"2019","unstructured":"Cai C, Zhi Y, Wang K, Zhang P, Ji Z, Xie C, et al. CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p. Onco Targets Ther. 2019;12:3363\u201372.","journal-title":"Onco Targets Ther"},{"key":"2382_CR37","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.bbrc.2017.07.162","volume":"493","author":"Z Kong","year":"2017","unstructured":"Kong Z, Wan X, Zhang Y, Zhang P, Zhang Y, Zhang X, et al. Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer. Biochem Biophys Res Commun. 2017;493:1217\u201323.","journal-title":"Biochem Biophys Res Commun"},{"key":"2382_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1139\/bcb-2019-0211","volume":"98","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Chen CJ, Lin ZY, Li JX, Liu J, Lin FJ, et al. Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p\/WISP1 pathway. Biochem Cell Biol. 2020;98:396\u2013404.","journal-title":"Biochem Cell Biol"},{"key":"2382_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1156","volume":"13","author":"L Ding","year":"2023","unstructured":"Ding L, Zheng Q, Lin Y, Wang R, Wang H, Luo W, et al. Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavage. Clin Transl Med. 2023;13: e1156.","journal-title":"Clin Transl Med"},{"key":"2382_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2019.10.006","volume":"468","author":"Z Shen","year":"2020","unstructured":"Shen Z, Zhou L, Zhang C, Xu J. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2020;468:88\u2013101.","journal-title":"Cancer Lett"},{"key":"2382_CR41","first-page":"5303","volume":"24","author":"XD Weng","year":"2020","unstructured":"Weng XD, Yan T, Liu CL. Circular RNA_LARP4 inhibits cell migration and invasion of prostate cancer by targeting FOXO3A. Eur Rev Med Pharmacol Sci. 2020;24:5303\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2382_CR42","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1158\/1541-7786.MCR-22-0271","volume":"21","author":"Z Kong","year":"2023","unstructured":"Kong Z, Lu Y, Yang Y, Chang K, Lin Y, Huang Y, et al. m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1\/HuR. Mol Cancer Res. 2023;21:1342\u201355.","journal-title":"Mol Cancer Res"},{"key":"2382_CR43","doi-asserted-by":"publisher","first-page":"11289","DOI":"10.2147\/OTT.S272294","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Shi Z, Li Z, Wang X, Zheng P, Li H. Circ_0057553\/miR-515-5p regulates prostate cancer cell proliferation, apoptosis, migration, invasion and aerobic glycolysis by targeting YES1. Onco Targets Ther. 2020;13:11289\u201399.","journal-title":"Onco Targets Ther"},{"key":"2382_CR44","doi-asserted-by":"publisher","first-page":"1579490","DOI":"10.1155\/2016\/1579490","volume":"2016","author":"L Wan","year":"2016","unstructured":"Wan L, Zhang L, Fan K, Cheng ZX, Sun QC, Wang JJ. Circular RNA-ITCH suppresses lung cancer proliferation via inhibiting the Wnt\/beta-catenin pathway. Biomed Res Int. 2016;2016:1579490.","journal-title":"Biomed Res Int"},{"key":"2382_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-018-0771-7","volume":"17","author":"C Yang","year":"2018","unstructured":"Yang C, Yuan W, Yang X, Li P, Wang J, Han J, et al. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17\/miR-224 and regulating p21, PTEN expression. Mol Cancer. 2018;17:19.","journal-title":"Mol Cancer"},{"key":"2382_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41420-022-00898-6","volume":"8","author":"L Chen","year":"2022","unstructured":"Chen L, Sun Y, Tang M, Wu D, Xiang Z, Huang CP, et al. High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2\/miRNA-198\/AMBRA1 signaling. Cell Death Discov. 2022;8:128.","journal-title":"Cell Death Discov"},{"key":"2382_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2019.12.014","volume":"472","author":"H Xu","year":"2020","unstructured":"Xu H, Sun Y, You B, Huang CP, Ye D, Chang C. Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217\/miRNA-646\/TGFbeta1\/p-Smad2\/3 signaling. Cancer Lett. 2020;472:151\u201364.","journal-title":"Cancer Lett"},{"key":"2382_CR48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41419-019-2028-9","volume":"10","author":"Y Feng","year":"2019","unstructured":"Feng Y, Yang Y, Zhao X, Fan Y, Zhou L, Rong J, et al. Circular RNA circ0005276 promotes the proliferation and migration of prostate cancer cells by interacting with FUS to transcriptionally activate XIAP. Cell Death Dis. 2019;10:792.","journal-title":"Cell Death Dis"},{"key":"2382_CR49","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1080\/21691401.2019.1648281","volume":"47","author":"C Jin","year":"2019","unstructured":"Jin C, Zhao W, Zhang Z, Liu W. Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer. Artif Cells Nanomed Biotechnol. 2019;47:3350\u20138.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2382_CR50","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/jcb.28239","volume":"121","author":"T Li","year":"2020","unstructured":"Li T, Sun X, Chen L. Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. J Cell Biochem. 2020;121:2118\u201326.","journal-title":"J Cell Biochem"},{"key":"2382_CR51","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1007\/s10528-021-10160-w","volume":"60","author":"Y Wu","year":"2022","unstructured":"Wu Y. Circ_0044516 enriches the level of SARM1 as a miR-330-5p sponge to regulate cell malignant behaviors and tumorigenesis of prostate cancer. Biochem Genet. 2022;60:1346\u201361.","journal-title":"Biochem Genet"},{"key":"2382_CR52","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41417-022-00492-z","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu F, Feng Y, Xu X, Wang Y, Zhu S, et al. CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9. Cancer Gene Ther. 2022;29:1731\u201341.","journal-title":"Cancer Gene Ther"},{"key":"2382_CR53","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/bjc.2011.452","volume":"105","author":"K Araki","year":"2011","unstructured":"Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, Yajima T, et al. E\/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer. 2011;105:1885\u201393.","journal-title":"Br J Cancer"},{"key":"2382_CR54","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","volume":"38","author":"Z Yang","year":"2019","unstructured":"Yang Z, Qu CB, Zhang Y, Zhang WF, Wang DD, Gao CC, et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene. 2019;38:2516\u201332.","journal-title":"Oncogene"},{"key":"2382_CR55","doi-asserted-by":"publisher","first-page":"1878431","DOI":"10.1155\/2020\/1878431","volume":"2020","author":"Q Lin","year":"2020","unstructured":"Lin Q, Cai J, Wang QQ. The significance of circular RNA DDX17 in prostate cancer. Biomed Res Int. 2020;2020:1878431.","journal-title":"Biomed Res Int"},{"key":"2382_CR56","doi-asserted-by":"publisher","first-page":"300060521992215","DOI":"10.1177\/0300060521992215","volume":"49","author":"H He","year":"2021","unstructured":"He H, Li J, Luo M, Wei Q. Inhibitory role of circRNA_100395 in the proliferation and metastasis of prostate cancer cells. J Int Med Res. 2021;49:300060521992215.","journal-title":"J Int Med Res"},{"key":"2382_CR57","doi-asserted-by":"publisher","first-page":"1358422","DOI":"10.3389\/fonc.2024.1358422","volume":"14","author":"H Sang","year":"2024","unstructured":"Sang H, Li L, Zhao Q, Liu Y, Hu J, Niu P, et al. The regulatory process and practical significance of non-coding RNA in the dissemination of prostate cancer to the skeletal system. Front Oncol. 2024;14:1358422.","journal-title":"Front Oncol"},{"key":"2382_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13046-022-02391-5","volume":"41","author":"L Ding","year":"2022","unstructured":"Ding L, Wang R, Zheng Q, Shen D, Wang H, Lu Z, et al. circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA. J Exp Clin Cancer Res. 2022;41:187.","journal-title":"J Exp Clin Cancer Res"},{"key":"2382_CR59","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.21037\/tau-24-276","volume":"13","author":"X Sun","year":"2024","unstructured":"Sun X, Huang X, Liu L, Shen W, Zheng F, Liu M, et al. Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway. Transl Androl Urol. 2024;13:2358\u201375.","journal-title":"Transl Androl Urol"},{"key":"2382_CR60","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0022-5347(01)64270-8","volume":"158","author":"PC Walsh","year":"1997","unstructured":"Walsh PC. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. J Urol. 1997;158:1623\u20134.","journal-title":"J Urol"},{"key":"2382_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yexcr.2018.12.016","volume":"375","author":"B Jia","year":"2019","unstructured":"Jia B, Liu W, Gu J, Wang J, Lv W, Zhang W, et al. MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1. Exp Cell Res. 2019;375:73\u201381.","journal-title":"Exp Cell Res"},{"key":"2382_CR62","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12885-019-5798-7","volume":"19","author":"J Lai","year":"2019","unstructured":"Lai J, Yang H, Zhu Y, Ruan M, Huang Y, Zhang Q. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer. BMC Cancer. 2019;19:602.","journal-title":"BMC Cancer"},{"key":"2382_CR63","doi-asserted-by":"crossref","unstructured":"Bhoir S, De Benedetti A. Targeting prostate cancer, the 'Tousled Way'. Int J Mol Sci. 2023;24.","DOI":"10.20944\/preprints202306.1180.v3"},{"key":"2382_CR64","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamaoncol.2015.1341","volume":"1","author":"ES Antonarakis","year":"2015","unstructured":"Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Nakazawa M, et al. Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer. JAMA Oncol. 2015;1:582\u201391.","journal-title":"JAMA Oncol"},{"key":"2382_CR65","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","volume":"371","author":"ES Antonarakis","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med. 2014;371:1028\u201338.","journal-title":"N Engl J Med"},{"key":"2382_CR66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41419-018-1048-1","volume":"10","author":"G Wu","year":"2019","unstructured":"Wu G, Sun Y, Xiang Z, Wang K, Liu B, Xiao G, et al. Preclinical study using circular RNA 17 and micro RNA 181c\u20135p to suppress the enzalutamide-resistant prostate cancer progression. Cell Death Dis. 2019;10:37.","journal-title":"Cell Death Dis"},{"key":"2382_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148818","volume":"930","author":"Y Li","year":"2024","unstructured":"Li Y, Fan A, Zhang Y, Meng W, Pan W, Wu F, et al. Circular RNA hsa_circ_0001610 promotes prostate cancer progression by sponging miR-1324 and upregulating PTK6. Gene. 2024;930: 148818.","journal-title":"Gene"},{"key":"2382_CR68","doi-asserted-by":"publisher","first-page":"10739","DOI":"10.1038\/s41598-019-47189-2","volume":"9","author":"J Greene","year":"2019","unstructured":"Greene J, Baird AM, Casey O, Brady L, Blackshields G, Lim M, et al. Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide. Sci Rep. 2019;9:10739.","journal-title":"Sci Rep"},{"key":"2382_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.605686","volume":"9","author":"J Greene","year":"2021","unstructured":"Greene J, Baird AM, Lim M, Flynn J, McNevin C, Brady L, et al. Differential CircRNA expression signatures may serve as potential novel biomarkers in prostate cancer. Front Cell Dev Biol. 2021;9: 605686.","journal-title":"Front Cell Dev Biol"},{"key":"2382_CR70","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-024-07246-9","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Qiu H, Dong Q, Yu H, Piao C, Li Z, et al. Androgen-targeted hsa_circ_0085121 encodes a novel protein and improves the development of prostate cancer through facilitating the activity of PI3K\/Akt\/mTOR pathway and enhancing AR-V7 alternative splicing. Cell Death Dis. 2024;15:848.","journal-title":"Cell Death Dis"},{"key":"2382_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.hoc.2019.08.017","volume":"34","author":"SC Kamran","year":"2020","unstructured":"Kamran SC, D\u2019Amico AV. Radiation therapy for prostate cancer. Hematol Oncol Clin North Am. 2020;34:45\u201369.","journal-title":"Hematol Oncol Clin North Am"},{"key":"2382_CR72","doi-asserted-by":"publisher","first-page":"8092","DOI":"10.3390\/curroncol30090587","volume":"30","author":"K Numakura","year":"2023","unstructured":"Numakura K, Kobayashi M, Muto Y, Sato H, Sekine Y, Sobu R, et al. The current trend of radiation therapy for patients with localized prostate cancer. Curr Oncol. 2023;30:8092\u2013110.","journal-title":"Curr Oncol"},{"key":"2382_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/CAD.0000000000001361","volume":"34","author":"T Yu","year":"2023","unstructured":"Yu T, Du H, Sun C. Circ-ABCC4 contributes to prostate cancer progression and radioresistance by mediating miR-1253\/SOX4 cascade. Anticancer Drugs. 2023;34:155\u201365.","journal-title":"Anticancer Drugs"},{"key":"2382_CR74","first-page":"480","volume":"37","author":"F Cai","year":"2022","unstructured":"Cai F, Li J, Zhang J, Huang S. Knockdown of Circ_CCNB2 sensitizes prostate cancer to radiation through repressing autophagy by the miR-30b-5p\/KIF18A axis. Cancer Biother Radiopharm. 2022;37:480\u201393.","journal-title":"Cancer Biother Radiopharm"},{"key":"2382_CR75","doi-asserted-by":"publisher","first-page":"11701","DOI":"10.2147\/CMAR.S273826","volume":"12","author":"H Li","year":"2020","unstructured":"Li H, Zhi Y, Ma C, Shen Q, Sun F, Cai C. Circ_0062020 knockdown strengthens the radiosensitivity of prostate cancer cells. Cancer Manag Res. 2020;12:11701\u201312.","journal-title":"Cancer Manag Res"},{"key":"2382_CR76","doi-asserted-by":"publisher","first-page":"7487","DOI":"10.2147\/CMAR.S257441","volume":"12","author":"S Du","year":"2020","unstructured":"Du S, Zhang P, Ren W, Yang F, Du C. Circ-ZNF609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through miR-501-3p\/HK2 axis. Cancer Manag Res. 2020;12:7487\u201399.","journal-title":"Cancer Manag Res"},{"key":"2382_CR77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijrobp.2023.11.033","volume":"119","author":"Y Sun","year":"2024","unstructured":"Sun Y, Tsai Y, Wood R, Shen B, Chen J, Zhou Z, et al. KDM3B single-nucleotide polymorphisms impact radiation therapy toxicity through circular RNA-mediated KDM3B expression and inflammatory responses. Int J Radiat Oncol Biol Phys. 2024;119:251\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2382_CR78","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.07.040","volume":"495","author":"D Chen","year":"2020","unstructured":"Chen D, Chou FJ, Chen Y, Tian H, Wang Y, You B, et al. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI\/circZEB1\/miR-141-3p\/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Lett. 2020;495:100\u201311.","journal-title":"Cancer Lett"},{"key":"2382_CR79","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-021-01388-6","volume":"20","author":"YD He","year":"2021","unstructured":"He YD, Tao W, He T, Wang BY, Tang XM, Zhang LM, et al. A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2\u201310 ng\/mL at initial biopsy. Mol Cancer. 2021;20:96.","journal-title":"Mol Cancer"},{"key":"2382_CR80","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, et al. Complications after systematic, random, and image-guided prostate biopsy. Eur Urol. 2017;71:353\u201365.","journal-title":"Eur Urol"},{"key":"2382_CR81","doi-asserted-by":"publisher","first-page":"599494","DOI":"10.3389\/fcell.2020.599494","volume":"8","author":"S Wang","year":"2020","unstructured":"Wang S, Su W, Zhong C, Yang T, Chen W, Chen G, et al. An eight-CircRNA assessment model for predicting biochemical recurrence in prostate cancer. Front Cell Dev Biol. 2020;8:599494.","journal-title":"Front Cell Dev Biol."},{"key":"2382_CR82","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1373\/clinchem.2019.305854","volume":"65","author":"M Kolling","year":"2019","unstructured":"Kolling M, Haddad G, Wegmann U, Kistler A, Bosakova A, Seeger H, et al. Circular RNAs in urine of kidney transplant patients with acute T cell-mediated allograft rejection. Clin Chem. 2019;65:1287\u201394.","journal-title":"Clin Chem"},{"key":"2382_CR83","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1016\/j.molcel.2024.11.022","volume":"84","author":"SH Boo","year":"2024","unstructured":"Boo SH, Shin MK, Hwang HJ, Hwang H, Chang S, Kim T, et al. Circular RNAs trigger nonsense-mediated mRNA decay. Mol Cell. 2024;84:4862.","journal-title":"Mol Cell"},{"key":"2382_CR84","doi-asserted-by":"publisher","first-page":"9268","DOI":"10.7150\/thno.46341","volume":"10","author":"H Rochow","year":"2020","unstructured":"Rochow H, Franz A, Jung M, Weickmann S, Ralla B, Kilic E, et al. Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality. Theranostics. 2020;10:9268\u201379.","journal-title":"Theranostics"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02382-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02382-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02382-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:43:44Z","timestamp":1740642224000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02382-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02382-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the responsible committee on human experimentation and with the Declaration of Helsinki of 1964 and later versions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}